Faron Pharmaceuticals Ltd | Company announcement | April 20, 2026 at 10:15:00 EEST

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:
Faron Pharmaceuticals OY
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
X
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv
Name
Heights Capital Management, Inc.
City and country of registered office (if applicable)
San Francisco, California
4. Full name of shareholder(s) (if different from 3.) v
Name
CVI Investments, Inc.
City and country of registered office (if applicable)
Cayman Islands
5. Date on which the threshold was crossed or reached vi:
15/04/2026
6. Date on which issuer notified (DD/MM/YYYY):
15/04/2026
7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached
10.13%
15.44%
25.58%
51,929,014
Position of previous notification (if
applicable)
8.37%
16.82%
25.19%


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type of
shares
ISIN code (if possible)
Number of voting rights ix
% of voting rights
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
Direct
(DTR5.1)
Indirect
(DTR5.2.1)
FI4000153309
20,569,014
31,360,000
10.13%
15.44%










SUBTOTAL 8. A
51,929,014
25.58%


B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument
Expiration
date x
Exercise/
Conversion Period xi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
Convertible Bond
08/02/2027
Anytime until maturity
13,440,000
6.62%
Convertible Bond
12/02/2028
Anytime until maturity
17,920,000
8.83%







SUBTOTAL 8. B 1
31,360,000
15.44%


B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrument
Expiration
date x
Exercise/
Conversion Period xi
Physical or cash
Settlement xii
Number of voting rights
% of voting rights





















SUBTOTAL 8.B.2




9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Heights Capital Management, Inc.
10.13%
15.44%
25.58%
CVI Investments, Inc.
10.13%
15.44%
25.58%













10. In case of proxy voting, please identify:
Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held


11. Additional information xvi
None

Place of completion
London, United Kingdom
Date of completion
15.04.2026

Läs mer på MFN

Ämnen i artikeln


Faron Pharmaceuticals

Senast

0,49

1 dag %

−2,18%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån